This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Akash Vijay Lingayat: Innovator in Pharmaceutical Formulations
Introduction
Akash Vijay Lingayat is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative formulations. His work is characterized by a focus on improving the efficacy and stability of pharmaceutical products.
Latest Patents
Akash holds a patent for an elagolix formulation. This pharmaceutical formulation includes elagolix sodium, magnesium oxide, and at least one disintegrating agent, such as crospovidone, croscarmellose sodium, sodium starch glycolate, and pregelatinized mixtures. The patent also describes a tablet that features a core formed from this pharmaceutical formulation. The elagolix sodium tablets demonstrate improved dissolution rates when tested using the Tablet Sink Time test. Additionally, these tablets exhibit enhanced storage stability, showing a reduction in degradation products during storage. He has 1 patent to his name.
Career Highlights
Akash has established himself as a key player in the pharmaceutical industry through his innovative work. He is currently associated with Sandoz AG, where he continues to develop and refine pharmaceutical formulations. His expertise in this area has contributed to advancements in medication delivery and effectiveness.
Collaborations
Throughout his career, Akash has collaborated with several professionals in the field. Notable coworkers include Vivek Battu and Amit Gupta, who have worked alongside him on various projects.
Conclusion
Akash Vijay Lingayat is a distinguished inventor whose contributions to pharmaceutical formulations have made a significant impact. His innovative approach to improving drug stability and efficacy continues to influence the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
